Search results
Results From The WOW.Com Content Network
Aerie Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie's two lead product candidates are once-daily therapies for lowering intraocular pressure with mechanisms to treat patients ...
Alcon Inc. ( German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]
Despite the company's reputable standing, counterfeit items do exist on Amazon, especially when it comes to best-selling items, namely, Apple products. Both Amazon and Apple police their items and ...
Marion Merrell Dow and its predecessor Marion Laboratories was a U.S. pharmaceutical company based in Kansas City, Missouri, from 1950 until 1996.. The company specialized in bringing to market drugs that had been discovered but unmarketed by other companies including Cardizem which treats arrhythmias and high blood pressure, Carafate (an ulcer treatment), Gaviscon (an antacid), Seldane (a ...
Amazon marked an amazing new first, topping $2 trillion in market value for the first time and becoming the fifth company to join the club. Shares of Amazon, which hit a record $193.61 per share ...
Aerie Pharmaceuticals is a spin-out from Duke research by co-founder Dr. David Epstein on retinal diseases, glaucoma and dry eye syndrome Durham pharma company acquired by international eye-care ...
The company offers free, two-day home delivery of prescriptions to Amazon Prime subscribers. Amazon Pharmacy requires customers to establish a secure pharmacy profile to manage insurance and medical information. At the time of its formation, Amazon Pharmacy's operation was limited to the United States.
Shares of Aerie Pharmaceuticals surged 16.3% on Feb. 26 after the ophthalmic pharmaceutical company’s 4Q revenue topped the Street’s estimates. Revenue in the fourth quarter surged 23% ...